CompletedNANCT06648239

Coronary Computed Tomographic Angiography to Optimize Diagnostic Yield of Invasive Angiography for Low-risk Patients Screened With Artificial Intelligence

Sponsor: Hamilton Health Sciences Corporation

Trial Details

ConditionCoronary Artery Disease
InterventionUsual Care; Centralized triage with risk score-based screening for obstructive CAD
PhaseNA
StatusCompleted
Participants251
Est. Completion1 Jan 2026
Last Updated11 May 2026

Primary Outcome

Rate of normal/non-obstructive CAD diagnosed through ICA

Eligibility Criteria

Inclusion Criteria

Patients are eligible to participate if they: 1) are ≥18 years of age; 2) are referred for non-urgent (elective) outpatient ICA; 3) have an indication for ICA that includes 'Rule out CAD', 'Cardiomyopathy', or 'Stable CAD'; and 4) are able to provide informed consent in English. Patients fulfilling any of the following criteria will be ineligible to participate: 1) prior high-quality coronary computed tomographic angiography (CCTA) within the last 5 years; 2) atrial fibrillation; 3) known severe renal dysfunction (GFR \<35); 4) planned non-coronary cardiac surgery; 5) any prior obstructive CAD, acute coronary syndrome, percutaneous coronary intervention, or coronary artery bypass graft; 6) known severe coronary artery calcification (calcium score \>250); or have a body mass index (BMI) exceeding 40.

Trial Sites

Countries

Canada
View Registry Entry

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service